Coen A. Stegeman

Active 1993–2024

72
Papers
18,062
Citations
60
h-index
71
i10-index

Citations

Citations per year for Coen A. Stegeman1974: 1 citations1993: 3 citations1994: 9 citations1995: 11 citations1996: 6 citations1997: 14 citations1998: 19 citations1999: 23 citations2000: 31 citations2001: 27 citations2002: 28 citations2003: 47 citations2004: 35 citations2005: 42 citations2006: 72 citations2007: 89 citations2008: 76 citations2009: 100 citations2010: 193 citations2011: 124 citations2012: 153 citations2013: 183 citations2014: 187 citations2015: 186 citations2016: 146 citations2017: 132 citations2018: 137 citations2019: 388 citations2020: 422 citations2021: 402 citations2022: 254 citations2023: 184 citations2024: 288 citations2025: 135 citations1975–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 866 citing papers, 20.6% of this breakdownUnited Kingdom: 417 citing papers, 9.9% of this breakdownNetherlands: 277 citing papers, 6.6% of this breakdownGermany: 276 citing papers, 6.6% of this breakdownFrance: 255 citing papers, 6.1% of this breakdownChina: 236 citing papers, 5.6% of this breakdownItaly: 235 citing papers, 5.6% of this breakdownCanada: 172 citing papers, 4.1% of this breakdownJapan: 135 citing papers, 3.2% of this breakdownSpain: 118 citing papers, 2.8% of this breakdownSweden: 115 citing papers, 2.7% of this breakdownAustralia: 111 citing papers, 2.7% of this breakdown
0%20.6%Other 23.5%

Fields

  • Medicine84.1%
  • Immunology and Microbiology7.8%
  • Biochemistry, Genetics and Molecular Biology5.9%
  • Environmental Science0.5%
  • Neuroscience0.4%
  • Nursing0.3%
  • Other1%

Topics

  • Vasculitis and related conditions17.3%
  • Otitis Media and Relapsing Polychondritis5%
  • Systemic Sclerosis and Related Diseases4.2%
  • Renal Diseases and Glomerulopathies3.5%
  • Acute Kidney Injury Research3.4%
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema2.7%
  • Other63.9%

Coauthors

All papers

Open in search
  1. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 2,726

  2. Long-term patient survival in ANCA-associated vasculitis

    Authors: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 930

  3. Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John H. Stone - New England Journal of Medicine 2013 cited by 727

  4. Genetically Distinct Subsets within ANCA-Associated Vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Augusto Vaglio, Stefan Wieczorek, Benjamin Wilde, Jochen Zwerina, Andrew J. Rees, David Clayton, Kenneth G. C. Smith - New England Journal of Medicine 2012 cited by 1,013

  5. Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis

    Authors: , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2007 cited by 1,116

  6. Tubular kidney injury molecule‐1 (KIM‐1) in human renal disease

    Authors: , , , , , - The Journal of Pathology 2007 cited by 478

  7. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2013 cited by 255

  8. Renal Survival in Proteinase 3 and Myeloperoxidase ANCA-Associated Systemic Vasculitis

    Authors: , , - Clinical Journal of the American Society of Nephrology 2013 cited by 176

  9. T Cells in Vascular Inflammatory Diseases

    Authors: , , , - Frontiers in Immunology 2014 cited by 92

  10. Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis

    Authors: , , , , , , , - Arthritis & Rheumatism 2011 cited by 357

  11. High Urinary Excretion of Kidney Injury Molecule-1 Is an Independent Predictor of Graft Loss in Renal Transplant Recipients

    Authors: , , , , , , , , , - Transplantation 2007 cited by 201

  12. Kidney histopathology in lethal human sepsis

    Authors: , , , , , , , , - Critical Care 2018 cited by 102

  13. EULAR recommendations for the management of large vessel vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2008 cited by 673

  14. A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 54

  15. Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's Granulomatosis

    Authors: , , , - New England Journal of Medicine 1996 cited by 778

  16. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody–associated systemic vasculitis: Anti–proteinase 3–mediated neutrophil activation is independent of the role of CD177‐expressing neutrophils

    Authors: , , , , , , , , - Arthritis & Rheumatism 2009 cited by 93

  17. Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis

    Authors: , , , , , - Annals of Internal Medicine 1994 cited by 724

  18. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement

    Authors: , , , - Kidney International 2003 cited by 161

  19. Increased miR-142-3p Expression Might Explain Reduced Regulatory T Cell Function in Granulomatosis With Polyangiitis

    Authors: , , , , , , , , - Frontiers in Immunology 2019 cited by 38

  20. CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis

    Authors: , , , , , , , , , , , , - Journal of Autoimmunity 2022 cited by 19

  21. EULAR recommendations for the management of primary small and medium vessel vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2008 cited by 989

  22. Immediate Postoperative Renal Function Deterioration in Cardiac Surgical Patients Predicts In-Hospital Mortality and Long-Term Survival

    Authors: , , , , , , - Journal of the American Society of Nephrology 2004 cited by 471

  23. Protective role of endothelial nitric oxide synthase

    Authors: , , , , - The Journal of Pathology 2002 cited by 376

  24. Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

    Authors: , , , , , , , - Clinical Journal of the American Society of Nephrology 2019 cited by 73